Development of transcriptomic biomarker signature in human saliva to detect lung cancer

[1]  Lei Zhang,et al.  Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.

[2]  Peter Beyerlein,et al.  Diagnostic potential of saliva: current state and future applications. , 2011, Clinical chemistry.

[3]  Paul F. Pinsky,et al.  Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. , 2011, Radiology.

[4]  Hua Xiao,et al.  Proteomics and its applications for biomarker discovery in human saliva , 2011, Bioinformation.

[5]  W. Pang,et al.  Proteomic Analysis of Whole Human Saliva Detects Enhanced Expression of Interleukin-1 Receptor Antagonist, Thioredoxin and Lipocalin-1 in Cigarette Smokers Compared to Non-Smokers , 2010, International journal of molecular sciences.

[6]  U. Sack,et al.  Angiogenic markers in breath condensate identify non-small cell lung cancer. , 2010, Lung cancer.

[7]  David Elashoff,et al.  Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. , 2010, Gastroenterology.

[8]  D. Porteous,et al.  Sputum trace metals are biomarkers of inflammatory and suppurative lung disease. , 2010, Chest.

[9]  E. Birney,et al.  A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.

[10]  C. Pirker,et al.  EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases , 2009, Clinical Cancer Research.

[11]  David Elashoff,et al.  Electrochemical Sensor for Multiplex Biomarkers Detection , 2009, Clinical Cancer Research.

[12]  G. Eibl,et al.  Systemic Disease-Induced Salivary Biomarker Profiles in Mouse Models of Melanoma and Non-Small Cell Lung Cancer , 2009, PloS one.

[13]  N. Gotoh,et al.  The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment , 2009, Expert opinion on therapeutic targets.

[14]  R. Crystal,et al.  Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human. , 2009, Chest.

[15]  John R Yates,et al.  Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). , 2009, Journal of proteome research.

[16]  T. Church,et al.  A Prospectively Measured Serum Biomarker for a Tobacco-Specific Carcinogen and Lung Cancer in Smokers , 2009, Cancer Epidemiology Biomarkers & Prevention.

[17]  N. Viñolas,et al.  Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE , 2008, Tumor Biology.

[18]  Holly Janes,et al.  Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design , 2008, Journal of the National Cancer Institute.

[19]  David Elashoff,et al.  Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.

[20]  David Elashoff,et al.  Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. , 2008, Clinical chemistry.

[21]  R. Carano,et al.  Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models , 2008, Oncogene.

[22]  A. Vissink,et al.  Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[23]  S. Hirohashi,et al.  Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma , 2007, Cancer science.

[24]  P. Sebastiani,et al.  Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer , 2007, Nature Medicine.

[25]  Ron Edgar,et al.  NCBI GEO standards and services for microarray data , 2006, Nature Biotechnology.

[26]  Anil Potti,et al.  Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors , 2006, BMC Genomics.

[27]  N. Park,et al.  Characterization of RNA in Saliva , 2006, Clinical chemistry.

[28]  T. Byers,et al.  Lack of Association between Sputum Atypia and Chronic Obstructive Pulmonary Disease Mortality , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  D. Wong,et al.  Salivary diagnostics powered by nanotechnologies, proteomics and genomics. , 2006, Journal of the American Dental Association.

[30]  David Shitrit,et al.  Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. , 2005, The oncologist.

[31]  M. Posner,et al.  The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects , 2005, Journal of Translational Medicine.

[32]  M. Meyerson,et al.  EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. , 2005, The New England journal of medicine.

[33]  L. Mariani,et al.  Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer. , 2005, Cancer research.

[34]  K. Jirström,et al.  Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression , 2005, Breast Cancer Research and Treatment.

[35]  David Elashoff,et al.  Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.

[36]  Daniel A. Haber,et al.  Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways , 2004, Science.

[37]  Gang Liu,et al.  Effects of cigarette smoke on the human airway epithelial cell transcriptome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[39]  N. Viñolas,et al.  Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis , 2003, Tumor Biology.

[40]  Stephen S Hecht,et al.  Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. , 2002, The Lancet. Oncology.

[41]  M. von Knebel Doeberitz,et al.  Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP‐specific RT‐PCR , 2001, International journal of cancer.

[42]  T. Petty.  The early identification of lung carcinoma by sputum cytology , 2000, Cancer.

[43]  R. Weigel,et al.  PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. , 2000, Cancer research.

[44]  J. Jen,et al.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.

[45]  L. Tanoue,et al.  Molecular Origins of Cancer. Lung Cancer , 2010 .

[46]  Lei Zhang,et al.  Salivary biomarkers for clinical applications. , 2009, Molecular Diagnosis & Therapy.

[47]  Philip Smith,et al.  Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[48]  Terry M. Therneau,et al.  What Does PLIER Really Do? , 2008, Cancer informatics.

[49]  David Spizarny,et al.  Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. , 2005, Lung cancer.

[50]  D. Wong,et al.  RNA Profiling of Cell-free Saliva Using Microarray Technology , 2004, Journal of dental research.